Residential and transplant center neighborhood segregation and live donor liver transplant
Peer-Reviewed Publication
Updates every hour. Last Updated: 30-Oct-2026 16:16 ET (30-Oct-2026 20:16 GMT/UTC)
There is still time to apply for the 2026 Semmelweis–Richter Journalism Award.
Journalists from eligible European countries may submit entries in two categories: Women’s Health and Pharmaceutical Strategies and Innovation, with a special focus on cardiovascular therapies.
The National Institute of Environmental Health Sciences has awarded a five-year, $3.3 million grant to a University of Cincinnati College of Medicine researcher to study the potential cardiovascular toxicity of microplastics and nanoplastics.
A phase 1 clinical trial testing the safety of a leishmaniasis vaccine is set to begin in the coming months – the first vaccine created to protect against the disfiguring skin disease common in tropical regions of the world and gaining ground in the United States. The researcher who led development of the vaccine is the senior author of a New England Journal of Medicine review article published last week describing the difficulties of treating most forms of the disease and reporting that the live vaccine, found to be safe in animals, is expected to be tested in humans later this year.